Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
A 35-week, single-center, prospective, double-blind, controlled, randomized, 2x2 crossover,
interventional Phase II study, investigating the effect of treatment with dapagliflozin 10mg
od on Left Ventricular distensibility in patients with early HFpEF.